Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Saltzstein

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Chemotherapy (Florence, Italy)|January 31, 2008
Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosaD Saltzstein, B Wachs, R Perroncel, et al.
The Journal of Urology|May 20, 1999
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study GroupR U Anderson, D Mobley, B Blank, et al.
The Journal of Urology|May 20, 2008
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancerK Hendricksen, D Gleason, J M Young, et al.
Mayo Clinic Proceedings|April 27, 2001
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT StudyR A Appell, P Sand, R Dmochowski, et al.
Urology|July 11, 2001
A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of DurasphereD Lightner, C Calvosa, R Andersen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Chemotherapy (Florence, Italy)|January 31, 2008
Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosaD Saltzstein, B Wachs, R Perroncel, et al.
The Journal of Urology|May 20, 1999
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study GroupR U Anderson, D Mobley, B Blank, et al.
The Journal of Urology|May 20, 2008
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancerK Hendricksen, D Gleason, J M Young, et al.
Mayo Clinic Proceedings|April 27, 2001
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT StudyR A Appell, P Sand, R Dmochowski, et al.
Urology|July 11, 2001
A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of DurasphereD Lightner, C Calvosa, R Andersen, et al.
Pageof 2